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Background: Complementary and alternative medicine (CAM) is frequently used in the Middle East, especially to
treat chronic diseases such as infertility. We aimed to examine the prevalence, characteristics, and determinants of
CAM use, particularly herbs and antioxidant therapies, among infertile males presenting for infertility evaluation in
Jordan.
Methods: Demographic information, use of alternative and antioxidant therapies for infertility treatment, and
patients’ belief in efficacy and safety of the therapies used were collected using a face-to-face questionnaire. Data
were collected from 428 infertile male patients presenting at infertility clinics in Amman, the capital city of Jordan.
The study was conducted between April 2013 and September 2013.
Results: Of the 428 men who completed the questionnaire, 184 (43%) used at least one of the alternative and
antioxidant therapies specified in the questionnaire. Nutritional regime; vitamins, such as vitamins C and E; and
medicinal herbs, such as ginger, saw palmetto, and ginseng were the most commonly used therapies reported.
A correlation between the use of alternative and antioxidant therapies versus infertility duration was found.
Additionally, the majority of males using CAM did not inform their health care providers about their usage.
Conclusions: The high prevalence of CAM use among infertile male patients underscores the urge to assimilate
CAM into the education and training of health professionals, as well as to improve infertile patients’ knowledge of
the safe use of CAM modalities.
Keywords: CAM, Male infertility, Antioxidants, Medicinal plantsBackground
Infertility affects approximately 10–15% of all couples in
industrialized countries [1-3]. Approximately 30% to
50% of these cases are owing to male factor infertility
[2]. Male factor infertility is defined as a change in sperm
concentration, motility, and/or morphology in at least one
sample of two sperm analyses collected between 1 and
4 weeks [4].
The generation of oxidants, also known as reactive
oxygen species (ROS), in the male reproductive tract is
a concern because of their potential toxic effects at high
levels on sperm quality and function [5,6]. The oxygen
paradox is a challenge faced by all cells living underCorrespondence: S.bardaweel@ju.edu.jo
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unless otherwise stated.aerobic conditions, including spermatozoa. While oxygen
is required for life, its ROS metabolites endanger cell
survival and functions [7]. Male germ cells, at various
differentiation stages, generate minute amounts of ROS
that are required for sperm production and maturation
[8,9]. To preserve normal cell function, excess ROS must
be constantly eliminated by seminal plasma antioxidants.
Excessive ROS generation may adversely affect sperm
number, motility, quality, and function including damage
to sperm DNA integrity [10-12]. Several studies have
demonstrated that elevated ROS levels are detected in the
semen of 25% to 40% of infertile men [7,12,13]. Spermato-
zoa are intensely vulnerable to the damage provoked by
excessive ROS as their plasma membranes enclose consi-
derable amounts of polyunsaturated fatty acids [14] whiled. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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enzymes [7].
Enzymatic antioxidants, such as superoxide dismutase,
the glutathione peroxidase/glutathione reductase system,
and catalase [15], as well as non-enzymatic antioxidants,
such as ascorbate (vitamin C) [16], tocopherol (vitamin
E) [17], taurine, and hypotaurine [18], are available in
the seminal plasma to prevent critical damage provoked
by ROS. In fact, the seminal plasma of fertile men has a
higher total antioxidant capacity than the seminal plasma
of infertile men [19]. However, elevated levels of ROS
measured in the semen of infertile men are more likely
owing to increased ROS production rather than to
reduced antioxidant capacity of the seminal plasma [20].
While the available treatments for male infertility have
erratic success rates [21,22], assisted reproductive tech-
nologies, such as intrauterine insemination and in vitro
fertilization, potentially enhance the ability of infertile
men to contribute to a pregnancy. For many infertile
men, the lack of accessible successful medical therapies
has led to the use of alternative therapies, including the
use of herbs and antioxidants. The use of alternative the-
rapies in infertile men is usually associated with specula-
tion that some forms of male infertility are caused by
antioxidant deficiency. Therefore, the hypothesis is that
supplementary antioxidants may enhance their ability to
contribute to a pregnancy.
We aimed to gain insights into the patterns of use of
alternative and antioxidant therapies in infertile men in
Jordan. The prevalence and factors leading to the use of
such therapies among infertile men were also investigated.
Moreover, one of the objectives of the study was to find
out which complementary and alternative medicines
(CAM) are being used by infertile men, and whether they
believed in the effectiveness of these therapies.
Methods
Patient population
Verbal informed consent to participate in the study was
obtained based on a standard written statement. Ethical
approval for conducting the study was obtained from the
Institutional Review Board (IRB) at the Jordan University
Hospital (JUH) and the Scientific Committee at the Dean-
ship of Scientific Research at The University of Jordan.
Patient information for this study remained confidential
and within the institution.
Data were collected from male patients seeking inferti-
lity treatment in two types of facilities: in vitro fertilization
(IVF) centers, at both public and private hospitals, and
infertility private clinics. In the private clinics, patients
were seen for routine examination and treatment of infer-
tility without any conception assistance being offered.
Patients at IVF centers were given conception assis-
tance. Both types of facilities were distributed indifferent areas of Amman, the capital city of Jordan. The
study took place between April 2013 and September
2013. Only male patients attending any of the study
centers were invited to complete the questionnaire.
Questionnaire design
The study questionnaire was structured based on preli-
minary discussions with patients and health professionals.
Additionally, the questionnaire was validated by a commit-
tee whose members were health professionals, consisting
of two fertility specialists, a pharmacist, and a nutritionist.
The questionnaire was written in English and then trans-
lated into Arabic. Both versions of the questionnaire were
checked by three members of the public with no medical
background.
The questionnaire was composed of 18 questions and
divided into three sections (Additional file 1). The first
section considered patients’ demographic information
that may have an impact on their health-related atti-
tudes. In particular, patients were asked about age,
education, and income level. In the second section, pa-
tients were asked about their medical and infertility
history. The third section involved questions about the
use of antioxidant therapies, as well as other forms of
alternative therapies for their infertility condition.
Additionally, patients were asked whether they informed
their principal healthcare provider about usage of the
reported alternative and antioxidant therapies.
The 18-point anonymous structured questionnaire was
given to 428 infertile males presenting at any of the study
centers. The study population was then subgrouped into
two groups, Group A and Group B. Group A included
patients who reported the use of alternative and anti-
oxidant therapies as an infertility treatment aid, and Group
B included patients who did not use any form of alterna-
tive and antioxidant therapies for their infertility treatment.
Data analysis
Data were coded, entered, and analyzed using the Statis-
tical Package for Social Sciences program (SPSS) database
for Windows, version 17 (SAS Institute, Cary, NC, USA).
The analysis of answers involved descriptive quantitative
statistics, like frequency and percentage. Chi-square and
Fisher exact tests were used to test for significant associ-
ation between groups. All hypothesis testing was two-
sided, with a probability value of 0.05 deemed significant.
Results
The present study investigated the use of alternative and
antioxidant therapy for infertility treatment among males
in Jordan. A total of 500 questionnaires were distributed,
of which 428 were completed (response rate = 85.6%).
Table 1 summarizes the demographic characteristics of
the study population. Study participants were mostly middle
Table 1 Characteristics of infertile males participating in
the study at Amman, Jordan 2013 (N = 428)
Characteristic Number Percentage






Over 46 32 7.5
Education (N = 428)
Primary school 16 3.7
High school 56 13.1
Community college 148 34.6
Undergraduate studies 175 40.9
Postgraduate studies 33 7.7
Income JDa (N = 418)b
Less than 500 JD 51 12.2
500–1000 JD 210 50.2
1000–1500 JD 93 22.2
1500–2000 JD 36 8.6
More than 2000 JD 28 6.7
Occupation (N = 414)b
Employee in medical sector 76 18.3
Employee in non medical sector 263 63.5
Business owner 37 8.9
Retired 26 6.3
Unemployed 12 2.9
Infertility period (N = 428)
1–2 years 41 9.6
2–4 years 178 41.6
More than 4 years 209 48.8
aJordanian Dinar (JD 0.71 = USD 1.0).









































Figure 1 Prevalence of alternative and antioxidant therapies
used for infertility treatment among participants by age group.
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fairly educated, with 41% (175/428) holding bachelor’s
degrees. The patient population was of an intermediate
economic level, earning 500–1000 JD monthly (50%,
210/418). Most patients had a male factor infertility
disease course of more than 2 years (90%, 387/428).
Of the 428 infertile men who completed the question-
naire, alternative and antioxidant therapies used for in-
fertility treatment were encountered in 43% of patients
(184/428) (Group A). Remarkably, more than two thirds
of the participants who used alternative and antioxidant
therapies were older than 36 years (Figure 1). The preva-
lence of alternative and antioxidant therapies considerably
decreased in younger ages, as Figure 1 clearly demonstrates.On the other hand, interest in alternative and antioxidant
therapies for infertility treatment diminished in older
patients (more than 46 years), suggesting a correlation
between age and the propensity to use CAM.
In the study sample, the tendency to use alternative
and antioxidant therapies in Group A participants
significantly (p < 0.05) increased as the period of inferti-
lity increased. As illustrated in Figure 2, about 71% (130/
184) of Group A participants suffered from infertility for
more than 4 years, compared with only 32% (79/244) of
Group B participants. Infertile males who reported the
use of alternative and antioxidant therapies were mostly
infertile for more than 4 years.
Our study population consisted of 18.3% (76/414) in-
fertile males who work in the medical field (e.g. nurses,
dentists, pharmacists, physicians). Our analysis clearly
demonstrates that this particular category of infertile
males was least interested in alternative and antioxidant
therapies for their infertility treatment. Indeed, only
2.7% (5/184) of infertile males who work in the medical
field reported the use of alternative and antioxidant
therapies in their therapy course.
According to our results, the main sources for alterna-
tive and antioxidant therapy recommendations were her-
balists at 92% (169/184), followed by family and friends at
37% (68/184). Nutritionists were also major sources for
recommendations, as 28% (51/184) of Group A received
recommendations to use alternative and antioxidant
therapies from licensed nutritionists. Very few recommen-
dations were made by physicians and pharmacists, as
shown in Figure 3.
Vitamins, such as C and E, were the most commonly
reported antioxidants used by Group A participants. Par-
ticipants specified that vitamins were used individually
and not as multivitamin products. Approximately, 51%
(94/184) of Group A participants reported the use of
Figure 2 Infertility period in Group A and B participants versus the use of alternative and antioxidant therapies for infertility treatment.
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declared the use of vitamin E. Minerals, such as selen-
ium and zinc, were reported by less than 20% of Group
A participants (Figure 4). Remarkably, almost 60% (112/
184) of Group A participants used herbal medicines for
their infertility treatment (Figure 4). Unfortunately, most
participants were not clear about the herbal medicines
used for their treatment. Participants described these
herbal formulations as herbal mixtures provided by
herbalists. Nevertheless, 40% (45/112) of participants
who reported the use of herbs clearly identified ginger,
saw palmetto, and ginseng as the main herbal constitu-
ents used in their adjunct treatment course.
By and large, nutritional regime appears to be the most
common alternative therapy used to treat infertility in
Group A participants. Almost 76% (141/184) of Group A
participants were on a nutritional regime during their
treatment course (Figure 4). Participants described their
diet as vitamin-rich with increased protein servings per
week. Foods like eggs, red meat, nuts, spinach, fish, butter,
and whole fat dairy products were specifically mentioned
when participants were asked about their diet. Only 36%
(51/141) of the patients obtained their diet from nutrition-






























Figure 3 Sources of recommendation for the usage of alternative andsources. Surprisingly, when the participants who consulted
nutritionists for their diet were asked whether they re-
ported any vitamin, mineral, or herbal supplement use to
their nutritionist, none of the answers were positive.
Likewise, statistical analysis of the response to a ques-
tion asking whether participants discussed their CAM
use, including their diet, with their physicians, revealed
that only 10.3% (19/184) of Group A participants
declared their CAM use to their health care provider.
Surprisingly, these participants asserted that their health
care providers neither approved nor denied their alterna-
tive and antioxidant therapy use. Participants indicated
that their health care providers were neutral towards
their CAM use.
Our results indicate that, relative to Group B partici-
pants, Group A participants trusted CAM therapies to
be safe and lack side effects. More than two thirds of
Group A participants (145/184) believed in the safety of
alternative and antioxidant therapies for the treatment
of their infertility. Only 21.2% (39/184) of Group A
participants were aware of potential side effects associ-
ated with some alternative and antioxidant therapies. In
contrast, 61% (149/244) of Group B participants appreci-
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Figure 4 Common alternative and antioxidant therapies used by infertile male patients in Jordan.
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184) and about 26% (63/244) of Group B participants
were diagnosed with other chronic medical conditions in
addition to their infertility. Both diabetes and high blood
pressure were the most commonly encountered chronic
diseases in the study sample (Figure 5A). Interestingly,
the tendency to use CAM therapies for chronic medical
conditions appears to be highly correlated to their use
for infertility treatment. Indeed, 70.1% (40/57) of Group
A participants who were diagnosed with other chronic
medical conditions reported the use of alternative ther-
apies for their medical condition treatment (Figure 5B).
On the other hand, only 31.8% (20/63) of Group B
participants who were diagnosed with other chronic
medical conditions reported the use of alternative the-
rapies for their medical condition treatment (Figure 5B).
When Group A participants were asked whether the
alternative and antioxidant therapies used for their infer-
tility were actually helpful to enhance their fertility, only
17% (31/184) of Group A participants reported positive
outcomes. However, only 6.5% (2/31) of those participants
could relate the reported positive outcomes to increased
pregnancy rate. Rather, 93.5% (29/31) of the participants
related the reported positive outcomes associated with
their use of alternative and antioxidant therapies to
general health status enhancement.
Despite the lack of evidence on the effectiveness of
alternative and antioxidant therapies for infertility treat-
ment, Group A participants generally related their use of
such therapies to effectiveness, on-shelf availability, low
cost, and high safety (Figure 6). Often, Group A partici-
pants believed that if alternative and antioxidant therapies
are not useful, then they are also not harmful. While there
was a reported low efficacy of alternative and antioxidant
therapies to treat infertility, a significant number of Group
A participants believed that their use of CAM therapies
was effective (Figure 6). This belief in effectiveness wasnot supported by any evidence related to increased preg-
nancy rates.
Discussion
Male infertility is a multi-faceted condition with several
potential contributing factors. Most commonly, occupa-
tional, environmental, and nutritional factors contribute
to sperm count and motility. Sperm count and motility
are ultimately responsible for fertility. Spermatogenesis
is an energetic process that demands an optimal intake
of antioxidants, minerals, and nutrients. Disruption of
the balance between these nutrients is suggested as one
of the possible etiologies of male infertility [8].
ROS, such as the superoxide anion, hydrogen pero-
xide, and nitric oxide, are needed for fertilization, and
thus are produced by spermatozoa. Nevertheless, high
concentrations of these free radicals can directly damage
sperm cells [8], resulting in male infertility. Antioxidants
are the first line of defense against ROS-induced male
infertility. Numerous clinical trials have investigated the
potential role of antioxidant therapy to relieve ROS-
induced male factor infertility [23]. Although antioxidants
are hypothesized to be useful therapeutic agents for male
infertility, the results of clinical trials are controversial
[23,24]. In this study, we investigated the patterns of
antioxidant use among infertile male patients in Jordan.
Additionally, the use of alternative therapies, including
herbal products and nutritional regime, were evaluated in a
population of 428 infertile males in Jordan.
The human body employs three general tactics of anti-
oxidants to safeguard against free radicals: endogenous
antioxidants, dietary antioxidants, and metal-binding
proteins [25]. Low molecular weight molecules, such as
coenzyme Q-10, and larger molecular enzymes, such as
superoxide dismutase, catalase, and glutathione peroxid-
ase, are classified as endogenous antioxidants [25]. Vi-
tamins C and E, carotenoids, and flavonoids are
Figure 6 Motives for alternative and antioxidant therapy use for infertility treatment in infertile male patients in Jordan.
A
B
Figure 5 Alternative and antioxidant therapies utilization by infertile males for the treatment of their chronic conditions. A. Prevalence
of chronic diseases in infertile male patients in Jordan. B. Patterns of alternative and antioxidant therapies used for the treatment of other chronic
diseases in Groups A and B.
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venging free radicals to break the chain reaction respon-
sible for lipid peroxidation. This class of antioxidants is
known as chain-breaking antioxidants [25]. On the other
hand, metal-binding proteins, such as albumin, ferritin,
and myoglobin, inactivate the transition metal ions that
catalyze the production of free radicals [26,27].
In this study sample, the use of chain-breaking anti-
oxidants, such as vitamin C and vitamin E, was more
frequently encountered relative to other antioxidants
(Figure 4). Vitamin C (ascorbic acid) is a water-soluble
ROS scavenger, while vitamin E is an important lipid-
soluble antioxidant. The hydrophilicity and lipophilicity of
vitamins C and E may function synergistically to scavenge
ROS and protect spermatozoa. Although no decisive con-
clusion has been confirmed in regard to the beneficial role
of vitamins C and E in male infertility [23], some reports
suggest that sperm motility and characteristics deterio-
rated significantly when a combination of vitamins C and
E was used [23,28,29].
Additionally, our study demonstrates that a significant
percentage of men presenting for infertility assessment
have used herbs as adjunct therapies to enhance their
fertility (Figure 4). The potential of herbs to enhance male
fertility has not been extensively studied [30,31]. Accor-
ding to our results, ginger is one of the main herbal ingre-
dients used by Group A participants. Ginger extracts have
been widely studied for an extensive scope of biological
activities, especially antioxidant activities [32]. In rats,
ginger considerably reduced lipid peroxidation by sustai-
ning the activities of antioxidant enzymes superoxide
dismutase, catalase, and glutathione peroxides [32]. Saw
palmetto was also one of the main herbs used to treat in-
fertility among Group A participants. Recently, the use of
saw palmetto for the treatment of benign prostatic hyper-
plasia and lower urinary tract symptoms in males has
increased [33,34]. Nevertheless, the precise mechanism of
action of saw palmetto remains unknown.
Recent studies suggest several beneficial effects of gin-
seng to increase the antioxidant capacity of various tissues
[35]. Both Asian and American ginseng were shown to
enhance libido and copulatory performance in laboratory
animals [36,37]. The observed effects of ginseng are pos-
sibly related to its ginsenoside components on the central
nervous system and gonadal tissues [36,37]. In addition,
ginsenosides were shown to increase sperm motility [38]
and facilitate erectile dysfunction in males [39].
One of the main points addressed by our analysis is
the poor communication between the patients and their
health care providers. Only 10.3% (19/184) of Group A
participants declared their alternative and antioxidant
therapies to their physicians. Increased consumption of
certain antioxidants, regardless of their source, with the
concurrent use of herbal products rich in antioxidantshas been suggested to significantly deteriorate sperm
motility and characteristics [28,29]. Although our study
design was unable to establish a negative or positive cor-
relation between the use of alternative and antioxidant
therapies and an increase in pregnancy rate, the increased
prevalence of alternative and antioxidant therapies among
infertile males necessitates a clear and urgent need for
physicians to become more aware of this phenomenon
and conduct further research in this field [23].
Conclusions
This study provides results of a survey of infertile males
in Jordan (n = 428) seeking medical assistance for their
infertility. Our data show that the use of alternative and
antioxidant therapies for infertility treatment is more
common in middle-aged and fairly educated infertile
males who have suffered from infertility for more than
4 years. Nutritional regime, herbal formulations, and vi-
tamins such as vitamin C and E were the most popular
alternative and antioxidant therapies used in the study
population. Our results indicate that the majority of infer-
tile males who used alternative and antioxidant therapies
did not inform their health care providers about their ad-
junct therapies. Some of these adjunct treatments might
have adverse effects on the outcomes of conventional me-
dical treatment. Therefore, it is essential to inquire about
the use of these therapies by infertile males presenting at
infertility clinics.
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